Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid TumorsXun Huang, Meiyu Geng, Xiong Zhang et al.|Cell|2018Cited by 271
Global identification of phospho-dependent SCF substrates reveals a FBXO22 phosphodegron and an ERK-FBXO22-BAG3 axis in tumorigenesisPing Liu, Minjia Tan, Xinglong Jia et al.|Cell Death and Differentiation|2021Cited by 43